![Stuart Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Poulton
Corporate Officer/Principal at
KARYOPHARM THERAPEUTICS INC.
Net worth: 862 871 $ as of 30/05/2026
Profile
Stuart Poulton is Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. since 2022.
Formerly, Mr. Poulton was Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022, Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016, and Head-Clinical Operations at Eli Lilly & Co. Education includes graduate studies at The University of New South Wales and undergraduate studies at The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/05/2026 | 94,821 ( 0.42% ) | 862 871 $ | 30/05/2026 |
Stuart Poulton active positions
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 31/01/2022 |
Former positions of Stuart Poulton
| Companies | Position | End |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 31/12/2021 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2015 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Stuart Poulton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
- Stock Market
- Insiders
- Stuart Poulton
